EX-23.2 3 tm2134979d1_ex23-2.htm EXHIBIT 23.2

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated February 4, 2021 relating to the financial statements of Brainstorm Cell Therapeutics Inc., appearing in the Annual Report on Form 10-K of Brainstorm Cell Therapeutics Inc., for the year ended December 31, 2020.

 

/s/ Brightman Almagor Zohar & Co.
 
Brightman Almagor Zohar & Co.
Certified Public Accountants
A Firm in the Deloitte Global Network

 

Tel Aviv, Israel

December 10, 2021